Literature DB >> 32666143

Knee arthrodesis as last resort for persistent knee joint infections : Comparison of extramedullary and intramedullary treatment.

Dirk Zajonz1,2,3, Benedikt Zimmerlich4,5, Robert Möbius6, Melanie Edel4,6, Johanna Przybyl4, Andreas Höch4,6, Johannes K M Fakler4, Andreas Roth4, Mohamed Ghanem4.   

Abstract

BACKGROUND: Knee joint arthrodesis is an established treatment for periprosthetic infections (PPI) providing stability and pain relief. In this study the outcome after arthrodesis of the knee joint for persistent infections was compared and evaluated depending on the surgical procedure (intramedullary vs. extramedullary).
MATERIAL AND METHODS: In a retrospective case analysis, all patients who underwent knee joint arthrodesis between 1 January 2010 and 31 December 2016 were identified and divided into two groups: IMA and EMA. All patients were examined clinically and radiologically and the patient files were evaluated. In addition, the FIM score, the LEFS, the WHOQOL-BREF and NRS were evaluated.
RESULTS: The median LEFS score for the IMA group was 26 points and in the EMA group 2 points (p = 0.03). The IMA patients showed a median pain scale at rest of 0 and during exercise of 2. The EMA group recorded a pain scale of 3 at rest and 5 during exercise (p = 0.28 at rest; p = 0.43 during exercise). In the IMA group the median postsurgical leg length difference was -2.0 cm and -2.5 cm in the EMA group (p = 0.31). At the end of the follow-up examinations, the FIM score of patients in the IMA group was 74.5 points and 22 points in the EMA group (p = 0.07).
CONCLUSION: The study showed that no arthrodesis procedure is obviously superior with respect to the postoperative outcome. The IMA combines advantages especially in the early phase after surgery in terms of function as well as patient comfort and is therefore currently the procedure of choice. The attending physician should be familiar with the advantages and disadvantages of the various procedures in order to be able to make an individual decision and thus maximize the chance of treatment success.

Entities:  

Keywords:  Debridement; Gonarthrosis; Periprosthetic infection; Retrospective study; Total knee arthroplasty

Mesh:

Year:  2021        PMID: 32666143      PMCID: PMC7925473          DOI: 10.1007/s00132-020-03939-z

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  31 in total

Review 1.  [Management of periprosthetic infections of the knee].

Authors:  N Renz; C Perka; A Trampuz
Journal:  Orthopade       Date:  2016-01       Impact factor: 1.087

2.  Durable infection control and function with the PROSTALAC spacer in two-stage revision for infected knee arthroplasty.

Authors:  Christopher R Gooding; Bassam A Masri; Clive P Duncan; Nelson V Greidanus; Donald S Garbuz
Journal:  Clin Orthop Relat Res       Date:  2011-04       Impact factor: 4.176

3.  Total knee arthroplasty in Italy: reflections from the last fifteen years and projections for the next thirty.

Authors:  Emilio Romanini; Francesco Decarolis; Ilaria Luzi; Gustavo Zanoli; Michele Venosa; Paola Laricchiuta; Eugenio Carrani; Marina Torre
Journal:  Int Orthop       Date:  2018-10-06       Impact factor: 3.075

4.  Hip and Knee Section, Outcomes: Proceedings of International Consensus on Orthopedic Infections.

Authors:  William P Abblitt; Tiziana Ascione; Stefano Bini; Guillem Bori; Adam C Brekke; Antonia F Chen; Paul M Courtney; Craig J Della Valle; Claudio Diaz-Ledezma; Ayman Ebied; Yale J Fillingham; Thorsten Gehrke; Karan Goswami; George Grammatopoulos; Sameh Marei; Ali Oliashirazi; Javad Parvizi; Gregory Polkowski; Kordo Saeed; Adam J Schwartz; John Segreti; Noam Shohat; Bryan D Springer; Linda I Suleiman; Lee K Swiderek; Timothy L Tan; Chun Hoi Yan; Yi Rong Zeng
Journal:  J Arthroplasty       Date:  2018-10-19       Impact factor: 4.757

5.  Arthrodesis of the knee after failed infected total knee arthroplasty.

Authors:  Hans-Michael Klinger; Gunter Spahn; Wolfgang Schultz; Mike Herbert Baums
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-08-30       Impact factor: 4.342

6.  Patellofemoral arthroplasty versus total knee arthroplasty for patients with patellofemoral osteoarthritis: equal function and satisfaction but higher revision rate for partial arthroplasty at a minimum eight years’ follow-up.

Authors:  N D Clement; T A Howard; R J Immelman; D MacDonald; J T Patton; G M Lawson; R Burnett
Journal:  Bone Joint J       Date:  2019-01       Impact factor: 5.082

7.  The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria.

Authors:  Javad Parvizi; Timothy L Tan; Karan Goswami; Carlos Higuera; Craig Della Valle; Antonia F Chen; Noam Shohat
Journal:  J Arthroplasty       Date:  2018-02-26       Impact factor: 4.757

8.  Two-stage approach to primary TKA in infected arthritic knees using intraoperatively molded articulating cement spacers.

Authors:  Aseem Arif Shaikh; Chul-Won Ha; Yong-Geun Park; Yong-Beom Park
Journal:  Clin Orthop Relat Res       Date:  2014-03-06       Impact factor: 4.176

9.  Knee Arthrodesis Outcomes After Infected Total Knee Arthroplasty and Failure of Two-stage Revision With an Antibiotic Cement Spacer.

Authors:  Matthew Robinson; Hristo I Piponov; Andrew Ormseth; Cory W Helder; Brian Schwartz; Mark H Gonzalez
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2018-01-03

10.  Outcome of total knee replacement following explantation and cemented spacer therapy.

Authors:  Mohamed Ghanem; Dirk Zajonz; Juliane Bollmann; Vanessa Geissler; Torsten Prietzel; Michael Moche; Andreas Roth; Christoph-E Heyde; Christoph Josten
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2016-03-24
View more
  1 in total

1.  Low complication rate and better results for intramedullary nail - arthrodesis for infected knee joints compared to external fixator-a series of one hundred fifty two patients.

Authors:  Arnold J Suda; Xaver Brachtendorf; Marco Tinelli; Raed Wagokh; Ghaith Abou-Nouar; Oliver E Bischel
Journal:  Int Orthop       Date:  2021-04-23       Impact factor: 3.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.